Integer Holdings beats Q4 estimates with 23% EPS growth and margin gains, but shares slide 4% as softer 2026 guidance tempers investor enthusiasm.
Integer Holdings Corporation (ITGR) Q4 2025 Earnings Call Transcript
While the top- and bottom-line numbers for Integer (ITGR) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Integer (ITGR) came out with quarterly earnings of $1.76 per share, beating the Zacks Consensus Estimate of $1.7 per share. This compares to earnings of $1.43 per share a year ago.
ITGR leans on R&D and MedTech scale after a solid Q3 2025, but slower product adoption and supplier reliance cloud the near-term outlook.
Integer Holdings Corporation (ITGR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Integer Holdings posts strong Q3 results with earnings and revenue beat, but shares plunge on a softer 2026 growth outlook.
The headline numbers for Integer (ITGR) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Investors with an interest in Medical - Instruments stocks have likely encountered both Integer (ITGR) and SONOVA HOLDING (SONVY). But which of these two companies is the best option for those looking for undervalued stocks?
Investors interested in Medical - Instruments stocks are likely familiar with Integer (ITGR) and Penumbra (PEN). But which of these two stocks offers value investors a better bang for their buck right now?